Skip to main content
Top

25-03-2024 | Aortic Valve Replacement | Original Article

Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Authors: Fukuishi Yuta, Hiroyuki Kawamori, Takayoshi Toba, Takashi Hiromasa, Satoru Sasaki, Tomoyo Hamana, Hiroyuki Fujii, Yuto Osumi, Seigo Iwane, Tetsuya Yamamoto, Shota Naniwa, Yuki Sakamoto, Koshi Matsuhama, Ken-ichi Hirata, Hiromasa Otake

Published in: Heart and Vessels

Login to get access

Abstract

Background

Murray law-based quantitative flow ratio (μQFR) is a novel computational method that enables accurate estimation of fractional flow reserve (FFR) using a single angiographic projection. However, its diagnostic value in patients with severe aortic stenosis (AS) remains unclear.

Method

We included 25 consecutive patients who underwent transcatheter aortic valve replacement (TAVR) for severe AS with intermediate or greater (30–90%) coronary artery disease (CAD). Pre- and post-TAVR μQFR, QFR, instantaneous flow reserve (iFR), and post-TAVR invasive FFR values were measured. We evaluated the diagnostic performance of pre-TAVR μQFR, QFR, and iFR using post-TAVR FFR ≤ 0.80 as a reference standard of ischemia.

Result

Pre-TAVR μQFR was significantly correlated with post-TAVR FFR (r = 0.73, p < 0.0001). The area under the curve of pre-TAVR μQFR on post-TAVR FFR ≤ 0.8 was 0.91 (95% confidence interval [CI] 0.77–0.98), comparable to that of pre-TAVR iFR (0.86 [95% CI 0.71–0.98], p = 0.97). The accuracy, sensitivity, specificity, and positive and negative predictive values of pre-TAVR μQFR on post-TAVR FFR ≤ 0.8 were 84.2% (95% CI 68.7–93.4), 61.6% (95% CI 31.6–86.1), 96.0% (95% CI 79.6–99.9), 88.9% (95% CI 52.9–98.3), and 82.8% (95% CI 70.6–90.6), respectively. For pre-TAVR iFR, these values were 76.5% (95% CI 58.8–89.3), 90.9% (95% CI 58.7–99.8), 69.6% (95% CI 47.1–86.8), 58.8% (95% CI 42.8–73.1), and 94.1% (95% CI 70.8–99.1), respectively.

Conclusion

μQFR could be useful for the physiological evaluation of patients with severe AS with concomitant CAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484CrossRefPubMed Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484CrossRefPubMed
2.
go back to reference David HA, Jeffrey JP, Michael JR, Steven JY, Joseph SC, Michael Deeb G, Thomas GG, Maurice B, James H Jr, Neal SK, Stan C, John H, William M, George Z, Peter T, Newell R, George P, Chad Hughes G, Kevin Harrison J, John C, Brijeshwar M, Mubashir M, Sharla C, Jae KO (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798CrossRef David HA, Jeffrey JP, Michael JR, Steven JY, Joseph SC, Michael Deeb G, Thomas GG, Maurice B, James H Jr, Neal SK, Stan C, John H, William M, George Z, Peter T, Newell R, George P, Chad Hughes G, Kevin Harrison J, John C, Brijeshwar M, Mubashir M, Sharla C, Jae KO (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798CrossRef
3.
go back to reference Martin BL, Craig RS, Michael M, Craig MD, Jeffrey WM, Lars GS, Murat TE, John GW, Gregory PF, Raj RM, David LB, Peter CB, Robert AG, Augusto DP, Joseph EB, Howard CH, Pamela SD, John LP, Jodi JA, William NA, Duolao W, Stuart P (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRef Martin BL, Craig RS, Michael M, Craig MD, Jeffrey WM, Lars GS, Murat TE, John GW, Gregory PF, Raj RM, David LB, Peter CB, Robert AG, Augusto DP, Joseph EB, Howard CH, Pamela SD, John LP, Jodi JA, William NA, Duolao W, Stuart P (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRef
4.
go back to reference Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GLIII, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380:1706–1715CrossRefPubMed Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GLIII, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380:1706–1715CrossRefPubMed
5.
go back to reference Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705CrossRefPubMed Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705CrossRefPubMed
6.
go back to reference Witberg G, Regev E, Chen AA, Barbash IM, Planer D, Vaknin-Assa H, Guetta V, Vukasinovic V, Orvin K, Danenberg HD, Segev A, Kornowski R (2017) The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Intv 10:1428–1435CrossRef Witberg G, Regev E, Chen AA, Barbash IM, Planer D, Vaknin-Assa H, Guetta V, Vukasinovic V, Orvin K, Danenberg HD, Segev A, Kornowski R (2017) The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Intv 10:1428–1435CrossRef
7.
go back to reference D’Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, Stefanini GG, Paradis JM, Omede P, Kodali S, D’Amico M, Rinaldi M, Salizzoni S (2018) Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention 14:e1169-1177CrossRefPubMed D’Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, Stefanini GG, Paradis JM, Omede P, Kodali S, D’Amico M, Rinaldi M, Salizzoni S (2018) Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention 14:e1169-1177CrossRefPubMed
8.
go back to reference Echavarría-Pinto M, Van de Hoef TP, Pacheco-Beltran N, Reyes-Carrera JE, Rangel-Alvarado E, Ledezma-Ledezma E, Aguilar-Castillo LA, Tovar-Becerra AI, Arellano JEM, Ramírez MNM, Muruaga M, Ibarra-Rangel AM, Montes-Collantes CA, Castrejon-Mora JL, Chong-Benitez IH, Vargas-Torrrescano LH, García-García HM (2022) Diagnostic agreement of quantitative flow ratio with fractional flow reserve in a Latin-American population. Int J Cardiovasc Imaging 38:1423–1430CrossRef Echavarría-Pinto M, Van de Hoef TP, Pacheco-Beltran N, Reyes-Carrera JE, Rangel-Alvarado E, Ledezma-Ledezma E, Aguilar-Castillo LA, Tovar-Becerra AI, Arellano JEM, Ramírez MNM, Muruaga M, Ibarra-Rangel AM, Montes-Collantes CA, Castrejon-Mora JL, Chong-Benitez IH, Vargas-Torrrescano LH, García-García HM (2022) Diagnostic agreement of quantitative flow ratio with fractional flow reserve in a Latin-American population. Int J Cardiovasc Imaging 38:1423–1430CrossRef
9.
go back to reference Tu S, Ding D, Chang Y, Li C, Wijns W, Xu B (2021) Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: a novel method based on bifurcation fractal law. Catheter Cardiovasc Interv 97(Suppl 2):1040–1047CrossRefPubMed Tu S, Ding D, Chang Y, Li C, Wijns W, Xu B (2021) Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: a novel method based on bifurcation fractal law. Catheter Cardiovasc Interv 97(Suppl 2):1040–1047CrossRefPubMed
10.
go back to reference Sasaki S, Kawamori H, Toba T, Takeshige R, Fukuyama Y, Hiromasa T, Fujii H, Hamana T, Osumi Y, Iwane S, Yamamoto T (2023) Diagnostic accuracy of pre-transcatheter aortic valve replacement nitroglycerin-free fractional flow reserve-computed tomography-based physiological assessment in patients with severe aortic stenosis for predicting post-transcatheter aortic valve replacement ischemia. Circ J. https://doi.org/10.1253/circj.CJ-23-0312CrossRefPubMed Sasaki S, Kawamori H, Toba T, Takeshige R, Fukuyama Y, Hiromasa T, Fujii H, Hamana T, Osumi Y, Iwane S, Yamamoto T (2023) Diagnostic accuracy of pre-transcatheter aortic valve replacement nitroglycerin-free fractional flow reserve-computed tomography-based physiological assessment in patients with severe aortic stenosis for predicting post-transcatheter aortic valve replacement ischemia. Circ J. https://​doi.​org/​10.​1253/​circj.​CJ-23-0312CrossRefPubMed
11.
go back to reference Tu S, Echavarria-Pinto M, von Birgelen C, Holm NR, Pyxaras SA, Kumsars I, Lam MK, Valkenburg I, Toth GG, Li Y, Escaned J (2015) Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions. JACC Cardiovasc Interv 8:564–574CrossRefPubMed Tu S, Echavarria-Pinto M, von Birgelen C, Holm NR, Pyxaras SA, Kumsars I, Lam MK, Valkenburg I, Toth GG, Li Y, Escaned J (2015) Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions. JACC Cardiovasc Interv 8:564–574CrossRefPubMed
12.
go back to reference Xaplanteris P, Fournier S, Pijls NH, Fearon WF, Barbato E, Tonino PA, Engstrøm T, Kääb S, Dambrink JH, Rioufol G, Toth GG (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250–259CrossRefPubMed Xaplanteris P, Fournier S, Pijls NH, Fearon WF, Barbato E, Tonino PA, Engstrøm T, Kääb S, Dambrink JH, Rioufol G, Toth GG (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250–259CrossRefPubMed
13.
go back to reference Sud M, Han L, Koh M, Austin PC, Farkouh ME, Ly HQ, Madan M, Natarajan MK, So DY, Wijeysundera HC, Fang J (2020) Association between adherence to fractional flow reserve treatment thresholds and major adverse cardiac events in patients with coronary artery disease. JAMA 324:2406–2414CrossRefPubMed Sud M, Han L, Koh M, Austin PC, Farkouh ME, Ly HQ, Madan M, Natarajan MK, So DY, Wijeysundera HC, Fang J (2020) Association between adherence to fractional flow reserve treatment thresholds and major adverse cardiac events in patients with coronary artery disease. JAMA 324:2406–2414CrossRefPubMed
14.
go back to reference Zimmermann FM, Ferrara A, Johnson NP, Van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR (2015) Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 36:3182–3188CrossRefPubMed Zimmermann FM, Ferrara A, Johnson NP, Van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR (2015) Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 36:3182–3188CrossRefPubMed
15.
go back to reference Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, Frame A, Petraco R, Rajkumar C, Demir O, Iglesias JF (2018) Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc Interv 11:2019–2031CrossRefPubMedPubMedCentral Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, Frame A, Petraco R, Rajkumar C, Demir O, Iglesias JF (2018) Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc Interv 11:2019–2031CrossRefPubMedPubMedCentral
16.
go back to reference Vendrik J, Ahmad Y, Eftekhari A, Howard JP, Wijntjens GW, Stegehuis VE, Cook C, Terkelsen CJ, Christiansen EH, Koch KT, Piek JJ (2020) Long-term effects of transcatheter aortic valve implantation on coronary hemodynamics in patients with concomitant coronary artery disease and severe aortic stenosis. J Am Heart Assoc 9:e015133CrossRefPubMedPubMedCentral Vendrik J, Ahmad Y, Eftekhari A, Howard JP, Wijntjens GW, Stegehuis VE, Cook C, Terkelsen CJ, Christiansen EH, Koch KT, Piek JJ (2020) Long-term effects of transcatheter aortic valve implantation on coronary hemodynamics in patients with concomitant coronary artery disease and severe aortic stenosis. J Am Heart Assoc 9:e015133CrossRefPubMedPubMedCentral
17.
go back to reference Cortés C, Carrasco-Moraleja M, Aparisi A, Rodriguez-Gabella T, Campo A, Gutiérrez H, Julca F, Gómez I, San Román JA, Amat-Santos IJ (2021) Quantitative flow ratio—meta-analysis and systematic review. Catheter Cardiovasc Interv 97:807–814CrossRefPubMed Cortés C, Carrasco-Moraleja M, Aparisi A, Rodriguez-Gabella T, Campo A, Gutiérrez H, Julca F, Gómez I, San Román JA, Amat-Santos IJ (2021) Quantitative flow ratio—meta-analysis and systematic review. Catheter Cardiovasc Interv 97:807–814CrossRefPubMed
18.
go back to reference Choi KH, Lee SH, Lee JM, Hwang D, Zhang J, Kim J, Im SY, Kim HK, Nam CW, Doh JH, Shin ES (2021) Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease. Int J Cardiol 325:23–29CrossRefPubMed Choi KH, Lee SH, Lee JM, Hwang D, Zhang J, Kim J, Im SY, Kim HK, Nam CW, Doh JH, Shin ES (2021) Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease. Int J Cardiol 325:23–29CrossRefPubMed
19.
go back to reference Cortés C, Liu L, Berdin SL, Fernández-Corredoira PM, Zhang R, Schäfer U, López M, Diarte JA, Tu S, Gutiérrez-Chico JL (2022) Agreement between Murray law-based quantitative flow ratio (μQFR) and three-dimensional quantitative flow ratio (3D-QFR) in non-selected angiographic stenosis: a multicenter study. Cardiol J 29:388–395CrossRefPubMedPubMedCentral Cortés C, Liu L, Berdin SL, Fernández-Corredoira PM, Zhang R, Schäfer U, López M, Diarte JA, Tu S, Gutiérrez-Chico JL (2022) Agreement between Murray law-based quantitative flow ratio (μQFR) and three-dimensional quantitative flow ratio (3D-QFR) in non-selected angiographic stenosis: a multicenter study. Cardiol J 29:388–395CrossRefPubMedPubMedCentral
20.
go back to reference Sejr-Hansen M, Christiansen EH, Ahmad Y, Vendrik J, Westra J, Holm NR, Thim T, Seligman H, Hall K, Sen S, Terkelsen CJ (2022) Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 99:68–73CrossRefPubMed Sejr-Hansen M, Christiansen EH, Ahmad Y, Vendrik J, Westra J, Holm NR, Thim T, Seligman H, Hall K, Sen S, Terkelsen CJ (2022) Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 99:68–73CrossRefPubMed
Metadata
Title
Diagnostic accuracy of Murray law-based quantitative flow ratio in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Authors
Fukuishi Yuta
Hiroyuki Kawamori
Takayoshi Toba
Takashi Hiromasa
Satoru Sasaki
Tomoyo Hamana
Hiroyuki Fujii
Yuto Osumi
Seigo Iwane
Tetsuya Yamamoto
Shota Naniwa
Yuki Sakamoto
Koshi Matsuhama
Ken-ichi Hirata
Hiromasa Otake
Publication date
25-03-2024
Publisher
Springer Japan
Published in
Heart and Vessels
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-024-02387-5